Creatine as nutritional supplementation and medicinal product.

肌酸 磷酸肌酸 一水肌酸 医学 肌酸激酶 药代动力学 药理学 内科学 能量代谢 安慰剂 病理 替代医学
作者
G. Benzi,Angelo Ceci
出处
期刊:PubMed 卷期号:41 (1): 1-10 被引量:40
链接
标识
摘要

Because of assumed ergogenic effects, the creatine administration has become popular practice among subjects participating in different sports. Appropriate creatine monohydrate dosage may be considered a medicinal product since, in accordance with the Council Directive 65/65/EEC, any substance which may be administered with a view to restoring, correcting or modifying physiological functions in humans beings is considered a medicinal product. Thus, quality, efficacy and safety must characterise the substance. In addition, the European Court of Justice has held that a product which is recommended or described as having preventive or curative properties is a medicinal product even if it is generally considered as a foodstuff and even if it has no known therapeutic effect in the present state of scientific knowledge. In biochemical terms, creatine administration increases creatine and phosphocreatine muscle concentration, allowing for an accelerated rate of ATP synthesis. In thermodynamics terms, creatine stimulates the creatine-creatine kinase-phosphocreatine circuit, which is related to the mitochondrial function as a highly organised system for the control of the subcellular adenylate pool. In pharmacokinetics terms, creatine entry into skeletal muscle is initially dependent on the extracellular concentration, but the creatine transport is subsequently downregulated. In pharmacodynamics terms, the creatine enhances the possibility to maintain power output during brief periods of high-intensity exercises. In spite of uncontrolled daily dosage and long-term administration, no researches on creatine monohydrate safety in humans were set up by standardised protocols of clinical pharmacology and toxicology, as currently occurs in phases I and II for products for human use. More or less documented side effects induced by creatine monohydrate are weight gain; influence on insulin production; feedback inhibition of endogenous creatine synthesis; long-term damages on renal function. A major point that related to the quality of creatine monohydrate products is the amount of creatine ingested in relation to the amount of contaminants present. During the industrial production of creatine monohydrate from sarcosine and cyanamide, variable amounts of contaminants (dicyandiamide, dihydrotriazines, creatinine, ions) are generated and, thus, their tolerable concentrations (ppm) must be defined and made consumers known. Furthermore, because sarcosine could originate from bovine tissues, the risk of contamination with prion of bovine spongiform encephalopathy (BSE or mad-cow disease) can t be excluded. Thus, French authorities forbade the sale of products containing creatine. Creatine, as other nutritional factors, can be used either at supplementary or therapeutic levels as a function of the dose. Supplementary doses of nutritional factors usually are of the order of the daily turnover, while therapeutic ones are three or more times higher. In a subject of 70 kg with a total creatine pool of 120 g, the daily turnover is approximately of 2 g. Thus, in healthy subjects nourished with fat-rich, carbohydrate, protein-poor diet and participating in a daily recreational sport, the oral creatine monohydrate supplementation should be of the order of the daily turnover, i.e., less than 2.5-3 g per day, bringing the gastrointestinal absorption to account. In healthy athletes submitted daily to high-intensity strength or sprint training, the maximal oral creatine monohydrate supplementation should be of the order of two times the daily turnover, i.e., less than 5-6 g per day for less than two weeks, and the creatine monohydrate supplementation should be taken under appropriate medical supervision. The oral administration of more that 6 g per day of creatine monohydrate should be considered as a therapeutic intervention and should be prescribed by physicians only in the cases of suspected or proven deficiency, or in conditions of severe stress and/or injury. The incorporation of creatine into the medicinal product class is supported also by the use in pathological conditions, e.g., some mitochondrial cytopathies, the guanidinoacetate methyltransferase deficiency, etc.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
考虑考虑完成签到,获得积分20
刚刚
王菲完成签到,获得积分10
刚刚
Ava应助科研通管家采纳,获得10
1秒前
CipherSage应助科研通管家采纳,获得10
1秒前
研友_VZG7GZ应助科研通管家采纳,获得10
1秒前
李健应助科研通管家采纳,获得10
1秒前
ding应助科研通管家采纳,获得10
1秒前
NexusExplorer应助科研通管家采纳,获得10
1秒前
FashionBoy应助科研通管家采纳,获得10
1秒前
隐形曼青应助科研通管家采纳,获得10
1秒前
Hello应助科研通管家采纳,获得10
1秒前
Lucas应助科研通管家采纳,获得10
1秒前
我是老大应助科研通管家采纳,获得10
1秒前
小二郎应助科研通管家采纳,获得10
2秒前
雨淋沐风完成签到,获得积分10
2秒前
香蕉觅云应助科研通管家采纳,获得10
2秒前
李爱国应助科研通管家采纳,获得10
2秒前
Jasper应助科研通管家采纳,获得10
2秒前
Emma完成签到 ,获得积分10
2秒前
bkagyin应助科研通管家采纳,获得10
2秒前
大模型应助科研通管家采纳,获得10
2秒前
柒月完成签到,获得积分10
2秒前
2秒前
和谐的修洁完成签到,获得积分10
2秒前
彭于晏应助科研通管家采纳,获得10
2秒前
CipherSage应助科研通管家采纳,获得10
2秒前
CodeCraft应助科研通管家采纳,获得10
2秒前
小二郎应助科研通管家采纳,获得10
2秒前
2秒前
bc发布了新的文献求助10
3秒前
3秒前
3秒前
考虑考虑发布了新的文献求助10
4秒前
Ningxin完成签到,获得积分10
4秒前
4秒前
涌现发布了新的文献求助10
4秒前
Ava应助jia采纳,获得10
5秒前
杨森omg完成签到,获得积分10
6秒前
Lucas应助Wenxianhuzhu采纳,获得50
6秒前
6秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Le dégorgement réflexe des Acridiens 800
Defense against predation 800
A Dissection Guide & Atlas to the Rabbit 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3134421
求助须知:如何正确求助?哪些是违规求助? 2785363
关于积分的说明 7771655
捐赠科研通 2440968
什么是DOI,文献DOI怎么找? 1297647
科研通“疑难数据库(出版商)”最低求助积分说明 625023
版权声明 600812